SMi - Generics, Supergenerics and Patent Strategies

The pharmaceutical generics industry is a fast moving and consistently expanding one. With the much referenced patent cliff rapidly approaching for many and already passed for some all businesses are looking to generics for a source of additional revenue.

SMi's conference will provide an excellent overview of the industry at the moment. Attendees will hear case studies from the big players in the market showing how they have handled issues and how they see the industry moving forward. They will also be covering some of the current regulatory issues and also the big Parma perspective of their movements in the generic field.

Sean-Paul Brankin will speak on the topic, "Patent settlement agreements, a generic standpoint."